Patents/Assignees

Merck Sharp & Dohme LLC

193 patents in portfolio

US12299619utility2025
Adaptive Enterprise Risk Evaluation
0 cites
US12291538utility2025
Small Molecule Inhibitors of KRAS G12C Mutant
0 cites
US12280107utility2025
Pneumococcal Conjugate Vaccine Formulations
0 cites
US12281109utility2025
Inhibitors of Histone Deacetylase-3 Useful for the Treatment of Cancer, Inflammation, Neurodegeneration Diseases and Diabetes
0 cites
US12275729utility2025
Substituted Tetrahydroquinolin Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors
0 cites
US12263171utility2025
7-, 8-, and 10-substituted Amino Triazolo Quinazoline Derivatives as Adenosine Receptor Antagonists, Pharmaceutical Compositions and Their Use
0 cites
US12264134utility2025
Substituted Piperazine Amide Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors
0 cites
US12264139utility2025
Aryl Sulfonamides as BLT1 Antagonists
0 cites
US12258329utility2025
Pyrimidone Derivatives as Selective Cytotoxic Agents Against HIV Infected Cells
0 cites
US12246008utility2025
4-amino or 4-alkoxy-substituted Aryl Sulfonamide Compounds with Selective Activity in Voltage-gated Sodium Channels
0 cites
US12247031utility2025
Cyclobutyl Pyrazolopyrimidine PDE9 Inhibitors
0 cites
US12240867utility2025
Arginase Inhibitors and Methods of Use
0 cites
US12234265utility2025
Stabilized RSV F Proteins and Uses Thereof
0 cites
US12227536utility2025
Crystalline Forms of an NRTTI Compound
0 cites
US12220408utility2025
Treatment of Migraine
0 cites
US12215101utility2025
Pro Drugs of PDE10 Compounds
0 cites
US12215116utility2025
Arginase Inhibitors and Methods of Use
0 cites
US12208135utility2025
Formulations of Dengue Virus Vaccine Compositions
0 cites
US12209145utility2025
PCSK9 Antagonist Compounds
0 cites
US12195445utility2025
2-amino-n-heteroaryl-nicotinamides as Na V 1.8 Inhibitors
0 cites

← PreviousPage 5 of 10Next →